Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
Detection of bcr/abl fusion and duplication of abl in a Ph-negative CML patient by the dual-color FISH method
1994-09-01

We report here the use of the fluorescence in situ hybridization (FISH) method to detect duplication of the abl gene and fusion of bcr/abl in a Ph-negative CML patient. The patient was in clinical remission when studied. Conventional cytogenetic analysis revealed an apparent normal diploid karyotype. Using a ...

Energy Citations Database

2
Trials Point to More Treatment Options for Chronic Myeloid Leukemia

... cells that contain the chromosome (known as the Philadelphia chromosome ) that harbors the BCR-ABL fusion gene, than ...

MedlinePLUS

3
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
2010-09-14

ABL-family proteins couple a highly regulated tyrosine kinase domain with an actin-binding and -bundling domain to carry out a set of unique and essential functions. The ABL genes are among the earliest identifiable genes encoding tyrosine kinases, and they show remarkable sequence conservation. ...

NSDL National Science Digital Library

4
Real-time quantitative reverse transcriptase polymerase chain reaction.
2010-01-01

The real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) has become the method of choice for the quantification of specific mRNAs. This method is fast, extremely sensitive, and accurate, requires only very small amounts of input RNA, and is relatively simple to perform. These characteristics have made it the method of choice for minimal residual disease monitoring such ...

PubMed

5
Inhibition of Rac GTPases in the Therapy of Chronic Myelogenous Leukemia.
2009-01-01

Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease (MPD) characterized by the expression of the p210-BCR/ABL fusion gene 1. This gene is produced by the reciprocal translocation (9; 22) (q34; q11) that juxtaposes the 3end of Abelson...

National Technical Information Service (NTIS)

6
Inhibition of Rac GTPases in the Therapy of Chronic Myelogenous Leukemia.
2008-01-01

Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease (MPD) characterized by the expression of the p210-BCR/ABL fusion gene 1. This gene is produced by the reciprocal translocation (9; 22) (q34; q11) that juxtaposes the 3 end of Abelso...

National Technical Information Service (NTIS)

7
Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia
2008-02-15

Using a quantitative single nucleotide polymorphism (SNP) assay we have investigated the changes in the expression of the BCR-ABL1 oncogene relative to the wild-type ABL1 and BCR alleles in cells from chronic myeloid leukemia (CML) patients not responding to therapy. The results show a progressive increase in the BCR-ABL1 oncogene ...

Energy Citations Database

8
Location of the BCR/ABL fusion genes on both chromosomes 9q34 in Ph negative chronic myeloid leukemia.
2002-08-01

We present two patients with Ph-negative chronic myeloid leukemia (CML) and fusion signal BCR/ABL on both chromosomes 9, located in region 9q34. The first case was a 27 years old man with CML. Molecular studies (RT-PCR) revealed the rearrangement in the major-BCR region and expression of chimeric BCR/ABL mRNA of b3a2 configuration. By ...

PubMed

9
A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants
2008-11-01

Studies of gene fusions in solid tumors are not as extensive as in hematological malignancies due to several technical and analytical problems associated with tumor heterogeneity. Nevertheless, there is a growing interest in the role of fusion genes in common epithelial tumors after the discovery of recurrent ...

PubMed Central

10
Studies on virus-induced cell fusion. Progress report, August 1, 1977--June 30, 1978
1978-07-01

We have previously postulated that wild-type Herpes Simplex Virus type I (HSV-1) infections are characterized by the presence of a fusion factor and a fusion inhibitor activity. The fusion inhibitor presumably is dominant so that a small fraction of cells fuse in a typical wild-type infection. Furthermore, the syn mutants isolated in ...

Energy Citations Database

First Page Previous Page 1 Next Page Last Page